Insider Transactions in Q4 2021 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.17%
|
$1,580,000
$79.04 P/Share
|
|
Dec 15
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
22,222
-13.9%
|
-
|
|
Dec 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$553,000
$79.4 P/Share
|
|
Dec 06
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-1.66%
|
$4,680,000
$78.0 P/Share
|
|
Nov 29
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.02%
|
$415,000
$83.2 P/Share
|
|
Nov 29
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.29%
|
$0
$0.46 P/Share
|
|
Nov 15
2021
|
Jonathan D Root Director |
BUY
Open market or private purchase
|
Indirect |
303
+47.49%
|
$26,967
$89.08 P/Share
|
|
Nov 15
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.2%
|
$30,000
$3.46 P/Share
|
|
Nov 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$644,000
$92.84 P/Share
|
|
Nov 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.72%
|
$430,000
$86.98 P/Share
|
|
Nov 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.12%
|
$0
$0.46 P/Share
|
|
Nov 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.07%
|
$2,760,000
$92.26 P/Share
|
|
Oct 28
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
3,722
-0.65%
|
$334,980
$90.17 P/Share
|
|
Oct 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.72%
|
$435,000
$88.0 P/Share
|
|
Oct 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.53%
|
$0
$0.46 P/Share
|
|
Oct 25
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
500
-0.09%
|
$45,000
$90.05 P/Share
|
|
Oct 20
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,778
-4.29%
|
$2,320,020
$90.1 P/Share
|
|
Oct 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.35%
|
$783,000
$87.49 P/Share
|
|
Oct 08
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$553,000
$79.49 P/Share
|
|
Oct 08
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.82%
|
$395,000
$79.4 P/Share
|
|
Oct 08
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.12%
|
$0
$0.46 P/Share
|
|
Oct 07
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
29,900
-2.4%
|
$2,421,900
$81.12 P/Share
|
|
Oct 06
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$8,000
$80.0 P/Share
|
|
Oct 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
70,000
-5.09%
|
$5,530,000
$79.17 P/Share
|
|
Oct 01
2021
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,190
+50.0%
|
-
|
|
Oct 01
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
231
-0.26%
|
$18,018
$78.7 P/Share
|
|
Oct 01
2021
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
240
-0.49%
|
$18,720
$78.7 P/Share
|
|
Oct 01
2021
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-0.07%
|
$36,036
$78.7 P/Share
|
|
Oct 01
2021
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-0.21%
|
$27,066
$78.7 P/Share
|